Diagnostics and therapy of epstein-barr virus in autoimmune disorders
CA 2277910 A1 · Owner: James, Judith A. · Inventors: James, Judith A.; Harley, John B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Data consistent with autoimmune disease being caused by Epstein-Barr virus are shown. Based on this evidence, an effective vaccine would prevent the autoimmune disease in those vaccinated modified or administered so that the , vaccine is not itself capable of inducing autoimmune disease. In the case of anti-Sm, structures to be avoided in Epstein-Barr virus-derived vaccine have been identified. Differences have been identified in the immune responses to Epstein-Barr infection between individuals who develop a specific autoimmune disease and those who do not. These differences are used to distinguish those who are at greater risk for developing specific autoimmune diseases from those …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 13, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 13, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 13, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.